The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike. Following a turbulent period marked by Brexit and the ...
Hosted on MSN1mon
Alzheimer's research presents new strategy for amyloid diagnosticsOn November 14, 2024, the EMA granted approval for Lecanemab in the ... And for some patients, such as people on blood thinners, this test is unsuitable. Moreover, CSF analysis provides indirect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback